We are live on ! Find out more
GC

Guggenheim Capital Portfolio holdings

AUM $12.9B
1-Year Est. Return 27.3%
This Fund
S&P 500
This Quarter Est. Return
-4.91%
1 Year Est. Return
+27.3%
3 Year Est. Return
+83.37%
5 Year Est. Return
+104.66%
10 Year Est. Return
+386.48%
AUM
$10.9B
AUM Growth
-$1.75B
Cap. Flow
-$1.1B
Cap. Flow %
-10.04%
Top 10 Hldgs %
12.82%
Holding
2,117
New
74
Increased
714
Reduced
1,076
Closed
223

Sector Composition

Rank Sector Weight
1 Technology 16.93%
2 Financials 11.3%
3 Healthcare 11.28%
4 Consumer Discretionary 7.69%
5 Industrials 7.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XPO icon
1676
XPO
XPO
$23.7B
$284K ﹤0.01%
10,749
-1,305
-11% -$40.6K
NS
1677
DELISTED
NuStar Energy L.P.
NS
$283K ﹤0.01%
20,999
+3,430
+20% +$51.6K
AVD icon
1678
American Vanguard Corp
AVD
$68.9M
$282K ﹤0.01%
15,067
-11,189
-43% -$233K
MATX icon
1679
Matsons
MATX
$6.18B
$281K ﹤0.01%
4,570
-3,610
-44% -$277K
WIRE
1680
DELISTED
Encore Wire Corp
WIRE
$281K ﹤0.01%
2,435
-5,834
-71% -$710K
DAN icon
1681
Dana Inc
DAN
$3.06B
$280K ﹤0.01%
24,553
-165,269
-87% -$2.5M
FMTX
1682
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$280K ﹤0.01%
+14,053
New +$185K
ARCC icon
1683
Ares Capital
ARCC
$14.4B
$277K ﹤0.01%
16,435
+850
+5% +$16.4K
FERG icon
1684
Ferguson
FERG
$49.8B
$277K ﹤0.01%
2,694
-74
-3% -$8.63K
KTB icon
1685
Kontoor Brands
KTB
$4.26B
$277K ﹤0.01%
8,257
+1,115
+16% +$41.3K
AMBA icon
1686
Ambarella
AMBA
$3.81B
$276K ﹤0.01%
4,907
-89
-2% -$6.6K
OCSL icon
1687
Oaktree Specialty Lending
OCSL
$1.14B
$276K ﹤0.01%
15,356
+791
+5% +$16.1K
OPP
1688
RiverNorth/DoubleLine Strategic Opportunity Fund
OPP
$191M
$274K ﹤0.01%
30,168
-399
-1% -$4.23K
VIR icon
1689
Vir Biotechnology
VIR
$1.49B
$274K ﹤0.01%
14,214
-15,873
-53% -$404K
FULT icon
1690
Fulton Financial
FULT
$4.64B
$273K ﹤0.01%
17,264
-7,965
-32% -$128K
GBDC icon
1691
Golub Capital BDC
GBDC
$3.42B
$271K ﹤0.01%
21,853
+1,589
+8% +$21.6K
UHAL icon
1692
U-Haul Holding Co
UHAL
$14.6B
$271K ﹤0.01%
5,330
+420
+9% +$22K
ARCB icon
1693
ArcBest
ARCB
$3.08B
$270K ﹤0.01%
3,701
-1,518
-29% -$122K
DVAX
1694
DELISTED
Dynavax Technologies
DVAX
$269K ﹤0.01%
25,800
-29,189
-53% -$380K
FNB icon
1695
FNB Corp
FNB
$6.75B
$269K ﹤0.01%
23,211
-11,978
-34% -$142K
MAIN icon
1696
Main Street Capital
MAIN
$5.48B
$269K ﹤0.01%
8,001
+432
+6% +$17.8K
SHLX
1697
DELISTED
Shell Midstream Partners, L.P.
SHLX
$269K ﹤0.01%
+16,990
New +$263K
BLKB icon
1698
Blackbaud
BLKB
$2.08B
$268K ﹤0.01%
6,064
+243
+4% +$13.1K
KYNB
1699
Kyntra Bio
KYNB
$29.4M
$267K ﹤0.01%
821
-44
-5% -$14.2K
FTI icon
1700
TechnipFMC
FTI
$27.3B
$267K ﹤0.01%
31,534
+6,903
+28% +$54.4K

Similar funds

Guggenheim Capital's Q3 2022 Portfolio in Review

As of Q3 2022, Guggenheim Capital held 2,117 positions worth $10.9B, down 14% from $12.7B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Guggenheim Capital withdrew a net $1.1B in Q3 2022, closing 223 positions and reducing 1,076 holdings. Its most notable exit was Pershing Square Tontine Holdings, Ltd., an estimated $367M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Guggenheim Capital opened a new position in Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust worth $11.6M.

  • Guggenheim Capital's largest Q3 2022 buy was Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust: 751,061 shares worth $11.6M.
  • Guggenheim Capital added most to Fox Class B in Q3 2022, an estimated $8.16M increase.
  • Guggenheim Capital's biggest Q3 2022 reduction was KKR Acquisition Holdings I Corp., cutting an estimated $36.5M.
  • Guggenheim Capital fully exited Pershing Square Tontine Holdings, Ltd. in Q3 2022, selling an estimated $367M.
  • Guggenheim Capital's ten largest holdings make up 13% of its $10.9B portfolio in Q3 2022.
  • Guggenheim Capital opened 74 new positions and closed 223 in Q3 2022.
  • Guggenheim Capital's portfolio value fell 14% quarter-over-quarter to $10.9B.

Based on Guggenheim Capital's 13F filing for Q3 2022, filed 14 Nov 2022.